SlideShare a Scribd company logo
Hepatology 101
August 20, 2015
Douglas Koo, MD, MPH, FACP
Department of Medicine, Hospital Medicine Service
Outline
Abnormal LFTs
Biliary tract disease
Ascites
LFTs
Case
HPI: duration of exposure and LFT abnormalities
PMH: DM, high BMI, autoimmune disease, transfusion
or transplant before 1972 (HBV) or 1992 (HCV)
Meds: new meds, vitamins, herbals, OTCs,
acetaminophen
FH: liver disease, autoimmune disease
SH: alcohol consumption, occupational exposure,
travel, from viral hepatitis endemic areas, IVDU,
tattoos
ROS: jaundice, rash, arthralgia, myalgia, anorexia,
weight loss, abdominal pain, fever, chills, pruritus
PE: Encephalopathy (inverted sleep-wake, irritability,
tremor, confusion), asterixis, jaundice, temporal
wasting, scleral or sublingual icterus, fetor hepaticus,
JVD, spider angiomata, gynecomastia, hepatomegaly,
splenomegaly, caput medusae, ascites, testicular
atrophy, thenar atrophy, palmar erythema,
Dupuytren’s contractures, LE edema
LFTs
• Total Protein 8.2
• Albumin 4.6
• TBili 18.9
• AST 1460
• ALT 2645
• Alk Phos 120
• PT 16.4
• INR 1.39
• PTT 35.8
LFTs: the players
LFT Abnormality measured Notes
Albumin Synthetic function Heavy alcohol use, chronic
inflammation, malnutrition
PT/INR Synthetic function Low vitamin K, warfarin
AST Hepatocellular damage High concentrations in cardiac
tissue, skeletal muscle, blood
ALT Hepatocellular damage Low concentrations in non-
hepatic tissue; more specific
Bilirubin Cholestasis, impaired
conjugation, biliary
obstruction
Hemolysis
Alkaline phosphatase Cholestasis, infiltrative
disease, biliary obstruction
Bone disease, leukemia,
lymphoma, CKD, CHF,
sarcoidosis, hyperthyroidism,
hyperparathyroidism,
pregnancy, post-prandial
LFT pattern is important for DDx
HEPATOCELLULAR
ALT, AST > Alk Phos
CHOLESTATIC
Alk Phos > ALT, AST
*Bilirubin can be elevated in both and do not help to distinguish
Hepatocellular pattern: AST, ALT in disease
Quinn PG, Johnston DE. Gastroenterologist 1997.
Hepatocellular pattern
Mild (<5x nl) Severe(>15x nl)
Steatosis/steatohepatitis
Chronic hepatitis B, C
Alcohol hepatitis (2:1 AST/ALT ratio)
Cirrhosis
Acute viral hepatitis (A-E, EBV, CMV)
Medications/toxins
Autoimmune hepatitis
Wilson’s disease
Hemochromatosis
Alpha1 antitrypsin deficiency
Celiac disease
Nonhepatic:
Hemolysis
Myopathy (3:1 ratio)
Thyroid disease
Strenuous exercise
Acute viral hepatitis (A-E, EBV, CMV)
Medications/toxins
Autoimmune hepatitis
Wilson’s disease
Ischemic hepatitis
Acute Budd-Chiari syndrome
Acute bile duct obstruction
Back to the case
Acute viral hepatitis (A-E, EBV, CMV)
Medications/toxins
Autoimmune hepatitis
Wilson’s disease
Ischemic hepatitis
Acute Budd-Chiari syndrome
Acute bile duct obstruction
• Total Protein 8.2
• Albumin 4.6
• TBili 18.9
• AST 1460
• ALT 2645
• Alk Phos 120
Hep A total Ab positive
Hep A IgMAb negative
Hep B surface Ab positive
Hep B surface Ag negative
Hep B core Ab negative
Hep B PCR <5 IU/mL
Hep C antibody negative
Hep C PCR <10 IU/mL
Narrowing our differential dx pays off
Cholestatic pattern
Confirm hepatobiliary source (check GGT)
RUQ sono
Dilated bile ducts Non-dilated bile ducts
Extrahepatic cholestasis Intrahepatic cholestasis
ERCP, MRCP, or CT
Check AMA
PBC ERCP, MRCP or biopsy
Malignant
- Hepatobiliary tumor
- Porta hepatis node
Benign
- Choledocholithiasis
- Chronic pancreatitis
- HIV cholangiopathy
- Parasitic infections
PBC
PSC
TPN
Sepsis
Pregnancy
Hepatic congestion/CHF
Drugs (steroids, Bactrim)
Infiltrative diseases (sarcoid, amyloid,
lymphoma,TB, fungal, HCC, mets)
Isolated hyperbilirubinemia
Unconjugated/Indirect Conjugated/Direct
Increased production
- Hemolysis
- Dyserythropoiesis
-Transfusion
- Large hematoma resorption
Impaired uptake
- CHF
- Portosystemic shunt
- Meds
Impaired conjugation
- Gilbert’s syndrome
- Crigler-Najjar syndrome
- Hyperthyroidism
- hepatitis, cirrhosis,Wilson’s
*see pathway for Cholestatic pattern
Biliary tract disease
Biliary disease
Case
• 52F metastatic colon adenocarcinoma
– diagnosed 2y ago, mets to lung, liver, bone, peritoneum
– p/w fever 101 at home, chills, rigors, mild abdominal pain
• PMH/PSH: biliary stent placed 3wks prior, PE, hypothyroidism, depression,
GERD, colectomy, HAIP, cholecystectomy, liver resection, RFA lung mets
• MEDS: enoxaparin, synthroid, escitalopram, pantoprazole, celecoxib, fentanyl
patch, hydromorphone, laxatives
• SH: current 15pk-yr smoker, social EtOH, married
• ROS: +epigastric abd pain, +nausea, +vomiting, +rhinorrhea, +nasal
congestion, -dyspnea, -chest pain, -cough, -hematuria, -dysuria, +dark urine, -
jaundice
Workup
• PE: 37.6 80/54 112 18 95% RA, mild confusion, mild epigastric tenderness
• Labs
• Lactic acid 3.1
• UA +urobilinogen
• Blood cultures pending
• CXR negative
5
0.4
15
10
32
262
146
3.3
118
24
7
159
5.4
85
307
11.7 33.5
1.1
0.6
3
121
Diagnosis
• Cholangitis; Biliary sepsis
– Ascending bacterial infection from duodenum
– Charcot’s triad (fever, RUQ pain, jaundice) 50-75%
– Reynold’s pentad (above + confusion and hypotension)
– Up to 40% mortality rate from multiorgan failure (liver, kidney)
– Significant endotoxemia
– Risk factors: biliary obstruction and stasis (stone, stricture), stent
– Imaging: US, CT, MRCP, ERCP, HIDA
Management of cholangitis
• Volume resuscitation/restore perfusion, antibiotics for polymicrobial
infection (check out our ID website); 80% will respond
• DRAINAGE!
• Electrolyte management, correct coagulopathy
• Consults: ICU, GI, IR (when percutaneous approach needed)
• Urgent! Persistent pain, fever, hypotension, confusion
Diagnosis
Management
Chole…
• Cholangitis
• Cholecystitis
– 90% gallstones
– 10% acalculous (critically ill, elderly, post-op)
– ERCP vs cholecystectomy vs cholecystostomy
• Chole(docho)lithiasis
– Saturation of bile with cholesterol or bilirubin + stasis
– Biliary “colic”: episodic RUQ or epigastric abdominal pain with quick
onset and slow resolution min to hours, nausea, fatty foods
• Imaging sensitivity:
– Cholelithiasis: U/S>CT
– Cholecystitis HIDA>CT=U/S
Ascites
Paracentesis
Indications
• To evaluate new onset ascites of
unclear etiology
• To evaluate for SBP
(spontaneous bacterial
peritonitis) in pt with known
ascites
• To perform large volume
paracentesis and provide comfort
or relieve respiratory
compromise
Contraindications
• Coagulopathy?
• Thrombocytopenia?
• DIC
• Abdominal wall collateral veins
• Abdominal wall cellulitis
• Surgical scars
• Caution in:
– Renal failure, organomegaly,
bowel obstruction, intrabdominal
adhesions, distended bladder
Sites
2 cm below umbilicus in midline
- linea alba lacks blood vessels
RLQ or LLQ 2 to 4 cm medial and
cephalad to ASIS
- lateral to rectus sheath to avoid
puncture of inferior epigastric artery
An ultrasound study demonstrated that a LLQ tap site is superior to a midline site; the
abdominal wall is relatively thinner in the left lower quadrant while the depth of fluid
is greater
Sakai H et al. Choosing the location for non-image guided abdominal paracentesis. Liver Int. 2005.
Advancing catheter through skin
Angular insertion Z-tract
or
Albumin after LVP in portal HTN & cirrhosis
• “interesting” “unresolved” “controversial”
• No study has shown a survival advantage
• Reasonable to forego albumin if <5L LVP
• I was taught give 50cc of 25% albumin (12.5g) per 2L removed
• NEJM article and video: recommend use of albumin if >5 L of ascites
removed (6 to 8 g per liter of fluid removed)
Appearance of ascites
• Clear/translucent yellow: uncomplicated in the setting of
cirrhosis
• Cloudy: infection
• Milky: “chylous ascites”, high triglyceride concentration,
cirrhosis or malignancy
• Pink/bloody: traumatic tap, leakage from punctured collateral
from previous tap, malignancy
• Brown/molasses: if bilirubin is greater than serum, concern
for ruptured gallbladder or perforated duodenal ulcer
Diagnosis and evaluation of patients with ascites. UpToDate.
2 questions: Infection? Portal HTN?
• Cell count: PMN > 250 cells/mm3
• If bloody or >50K RBCs, subtract 1
PMN for every 250 red cells
• Culture used to confirm diagnosis of
SBP
– Volume affects culture
sensitivity; goal 10cc per bottle
– Fill culture bottles at bedside
• SAAG = Ascites albumin value –
Serum albumin value
SBP treatment: RememberAlbumin
Malignant ascites
• Median survival 1-4 months
• Symptomatic relief
– Diuretics
– Tenckhoff catheter
Thank you!

More Related Content

What's hot

Hepatorenal syndrome
Hepatorenal syndromeHepatorenal syndrome
Hepatorenal syndrome
GOWTHAMAN Gowthaman.Tb
 
Calcium metabolism hypercalcemia
Calcium metabolism hypercalcemiaCalcium metabolism hypercalcemia
Calcium metabolism hypercalcemia
Ankit Gajjar
 
Approach to cholestatic jaundice
Approach to cholestatic jaundiceApproach to cholestatic jaundice
Approach to cholestatic jaundice
Ram Raut
 
Liver pathology & Disease condition
Liver pathology & Disease conditionLiver pathology & Disease condition
Liver pathology & Disease condition
Dr. Deepika Kenjale
 
autoimmune hepatitis
 autoimmune hepatitis autoimmune hepatitis
autoimmune hepatitis
RahulGupta1687
 
Biliary tract 2011
Biliary tract 2011Biliary tract 2011
Biliary tract 2011yansongfan
 
Jaundice
JaundiceJaundice
Jaundice
Abino David
 
Complications of ipaa
Complications of ipaaComplications of ipaa
Complications of ipaa
mostafa hegazy
 
2 cld
2 cld2 cld
Pathology of the large intestines
Pathology of the large intestinesPathology of the large intestines
Pathology of the large intestines
Orato Ogoti
 
PSA history and measurement
PSA history and measurementPSA history and measurement
PSA history and measurement
Alexander Small
 
Autosomal Dominant Polycystic Kidney Disease
Autosomal Dominant Polycystic Kidney DiseaseAutosomal Dominant Polycystic Kidney Disease
Autosomal Dominant Polycystic Kidney Disease
Wisit Cheungpasitporn
 
Interpretation of renal diagnostic tests
Interpretation of renal diagnostic testsInterpretation of renal diagnostic tests
Interpretation of renal diagnostic tests
Christos Argyropoulos
 
Diabetic nephropathy v7
Diabetic nephropathy v7Diabetic nephropathy v7
Diabetic nephropathy v7
Aiswarya Lekshmi
 
Obstructive jaundice 19_9_2014
Obstructive jaundice 19_9_2014Obstructive jaundice 19_9_2014
Obstructive jaundice 19_9_2014
DrAnum Ammad
 
Approach to Hematuria in primary care
Approach to Hematuria in primary careApproach to Hematuria in primary care
Approach to Hematuria in primary care
Hasan Ismail
 
Approach to a case of Obstructive jaundice
Approach to a case of Obstructive jaundiceApproach to a case of Obstructive jaundice
Approach to a case of Obstructive jaundice
Supreet Kumar
 

What's hot (20)

Hepatorenal syndrome
Hepatorenal syndromeHepatorenal syndrome
Hepatorenal syndrome
 
Diuretic renography
Diuretic renographyDiuretic renography
Diuretic renography
 
Calcium metabolism hypercalcemia
Calcium metabolism hypercalcemiaCalcium metabolism hypercalcemia
Calcium metabolism hypercalcemia
 
Approach to cholestatic jaundice
Approach to cholestatic jaundiceApproach to cholestatic jaundice
Approach to cholestatic jaundice
 
Liver pathology & Disease condition
Liver pathology & Disease conditionLiver pathology & Disease condition
Liver pathology & Disease condition
 
autoimmune hepatitis
 autoimmune hepatitis autoimmune hepatitis
autoimmune hepatitis
 
Biliary tract 2011
Biliary tract 2011Biliary tract 2011
Biliary tract 2011
 
Jaundice
JaundiceJaundice
Jaundice
 
Complications of ipaa
Complications of ipaaComplications of ipaa
Complications of ipaa
 
2 cld
2 cld2 cld
2 cld
 
Pathology of the large intestines
Pathology of the large intestinesPathology of the large intestines
Pathology of the large intestines
 
Proteinuria
ProteinuriaProteinuria
Proteinuria
 
PSA history and measurement
PSA history and measurementPSA history and measurement
PSA history and measurement
 
Autosomal Dominant Polycystic Kidney Disease
Autosomal Dominant Polycystic Kidney DiseaseAutosomal Dominant Polycystic Kidney Disease
Autosomal Dominant Polycystic Kidney Disease
 
Interpretation of renal diagnostic tests
Interpretation of renal diagnostic testsInterpretation of renal diagnostic tests
Interpretation of renal diagnostic tests
 
Diabetic nephropathy v7
Diabetic nephropathy v7Diabetic nephropathy v7
Diabetic nephropathy v7
 
Obstructive jaundice 19_9_2014
Obstructive jaundice 19_9_2014Obstructive jaundice 19_9_2014
Obstructive jaundice 19_9_2014
 
Approach to Hematuria in primary care
Approach to Hematuria in primary careApproach to Hematuria in primary care
Approach to Hematuria in primary care
 
Approach To a Patient with Ascitis
Approach To a Patient with AscitisApproach To a Patient with Ascitis
Approach To a Patient with Ascitis
 
Approach to a case of Obstructive jaundice
Approach to a case of Obstructive jaundiceApproach to a case of Obstructive jaundice
Approach to a case of Obstructive jaundice
 

Viewers also liked

Gi bleed
Gi bleedGi bleed
Gi bleed
derosaMSKCC
 
Pneumonia ty boot camp
Pneumonia ty boot campPneumonia ty boot camp
Pneumonia ty boot camp
derosaMSKCC
 
Immunotherapy 101
Immunotherapy 101Immunotherapy 101
Immunotherapy 101
derosaMSKCC
 
Anemia 101
Anemia 101Anemia 101
Anemia 101
derosaMSKCC
 
Work life fit and wellness
Work life fit and wellnessWork life fit and wellness
Work life fit and wellness
derosaMSKCC
 
Nf and tls
Nf and tlsNf and tls
Nf and tls
derosaMSKCC
 
Inpatient insulin orderset
Inpatient insulin ordersetInpatient insulin orderset
Inpatient insulin orderset
derosaMSKCC
 
Approach to abdominal pain
Approach to abdominal painApproach to abdominal pain
Approach to abdominal pain
derosaMSKCC
 
Empiric antibiotic management for major infections
Empiric antibiotic management for major infectionsEmpiric antibiotic management for major infections
Empiric antibiotic management for major infections
derosaMSKCC
 
Abdominal paracentesis
Abdominal paracentesisAbdominal paracentesis
Abdominal paracentesis
Saint Vincent Hospital
 
Approach to a patient with jaundice
Approach to a patient with jaundiceApproach to a patient with jaundice
Approach to a patient with jaundice
Ramarajan Sekar
 
An approach to jaundice
An approach to jaundiceAn approach to jaundice
An approach to jaundice
Kathiravan Ar
 
L2. approach to jaundice
L2. approach to jaundiceL2. approach to jaundice
L2. approach to jaundice
bilal natiq
 
Liver Function Tests - An Approach for Primary Care
Liver Function Tests - An Approach for Primary CareLiver Function Tests - An Approach for Primary Care
Liver Function Tests - An Approach for Primary Care
Jarrod Lee
 
Approach to cholestasis
Approach to cholestasisApproach to cholestasis
Approach to cholestasisdrsadhana86
 
Jaundice
JaundiceJaundice
Jaundice
Nikhil Bansal
 

Viewers also liked (20)

Gi bleed
Gi bleedGi bleed
Gi bleed
 
Pneumonia ty boot camp
Pneumonia ty boot campPneumonia ty boot camp
Pneumonia ty boot camp
 
Immunotherapy 101
Immunotherapy 101Immunotherapy 101
Immunotherapy 101
 
Anemia 101
Anemia 101Anemia 101
Anemia 101
 
Work life fit and wellness
Work life fit and wellnessWork life fit and wellness
Work life fit and wellness
 
Nf and tls
Nf and tlsNf and tls
Nf and tls
 
Inpatient insulin orderset
Inpatient insulin ordersetInpatient insulin orderset
Inpatient insulin orderset
 
Approach to abdominal pain
Approach to abdominal painApproach to abdominal pain
Approach to abdominal pain
 
Empiric antibiotic management for major infections
Empiric antibiotic management for major infectionsEmpiric antibiotic management for major infections
Empiric antibiotic management for major infections
 
Abdominal paracentesis
Abdominal paracentesisAbdominal paracentesis
Abdominal paracentesis
 
Approach to a patient with jaundice
Approach to a patient with jaundiceApproach to a patient with jaundice
Approach to a patient with jaundice
 
Jaundice
JaundiceJaundice
Jaundice
 
An approach to jaundice
An approach to jaundiceAn approach to jaundice
An approach to jaundice
 
An approach to jaundice
An approach to jaundiceAn approach to jaundice
An approach to jaundice
 
L2. approach to jaundice
L2. approach to jaundiceL2. approach to jaundice
L2. approach to jaundice
 
Viral hepatitis
Viral hepatitisViral hepatitis
Viral hepatitis
 
Abdominal paracentesis
Abdominal paracentesisAbdominal paracentesis
Abdominal paracentesis
 
Liver Function Tests - An Approach for Primary Care
Liver Function Tests - An Approach for Primary CareLiver Function Tests - An Approach for Primary Care
Liver Function Tests - An Approach for Primary Care
 
Approach to cholestasis
Approach to cholestasisApproach to cholestasis
Approach to cholestasis
 
Jaundice
JaundiceJaundice
Jaundice
 

Similar to Hepatology 101

Diagnosis & Management of Chronic Liver Disease.ppt
Diagnosis & Management of Chronic Liver Disease.pptDiagnosis & Management of Chronic Liver Disease.ppt
Diagnosis & Management of Chronic Liver Disease.ppt
KhooChunYik
 
Liver absite
Liver absiteLiver absite
Liver absite
KevinClimaco
 
Ascites
AscitesAscites
Ascites
alyaqdhan
 
Complications of Liver Disease (Academic Day Seminar)
Complications of Liver Disease (Academic Day Seminar)Complications of Liver Disease (Academic Day Seminar)
Complications of Liver Disease (Academic Day Seminar)
Joan Ng
 
Git Case Budd Chiari3.
Git Case Budd Chiari3.Git Case Budd Chiari3.
Git Case Budd Chiari3.
Shaikhani.
 
upper G I Bleed (non variceal)
upper G I Bleed (non variceal)upper G I Bleed (non variceal)
upper G I Bleed (non variceal)Juned Khan
 
Surgery cholangitis[1]
Surgery cholangitis[1]Surgery cholangitis[1]
Surgery cholangitis[1]coolboy101pk
 
acutepancreatitis-190207120812 (1).pdf (1).pptx
acutepancreatitis-190207120812 (1).pdf (1).pptxacutepancreatitis-190207120812 (1).pdf (1).pptx
acutepancreatitis-190207120812 (1).pdf (1).pptx
maleehazainab01
 
Chronic liver disease in children22.pptx
Chronic liver disease in children22.pptxChronic liver disease in children22.pptx
Chronic liver disease in children22.pptx
AmmaraHameed6
 
Management of ascites~8 b958
Management of  ascites~8 b958Management of  ascites~8 b958
Management of ascites~8 b958
Dr Hikmatullah Sherani
 
Hematemesis in children-Beyond Infancy
Hematemesis in children-Beyond InfancyHematemesis in children-Beyond Infancy
Hematemesis in children-Beyond Infancydivyaanair
 
Obstructive jaundice
Obstructive  jaundiceObstructive  jaundice
Obstructive jaundice
mostafa hegazy
 
Jaundice and LFT interpretation
Jaundice and LFT interpretationJaundice and LFT interpretation
Jaundice and LFT interpretation
Anahita Sharma
 
Liver Disease
Liver DiseaseLiver Disease
Liver Disease
SCDA
 
Acute GI bleed
Acute GI bleedAcute GI bleed
3. ASCITES part 1.pdf
3. ASCITES part 1.pdf3. ASCITES part 1.pdf
3. ASCITES part 1.pdf
Pratap Tiwari
 
Biliary emergencies.pptx
Biliary emergencies.pptxBiliary emergencies.pptx
Biliary emergencies.pptx
KTD Priyadarshani
 
seminar on Haematuria
seminar on Haematuriaseminar on Haematuria
seminar on Haematuria
Dr. Habibur Rahim
 

Similar to Hepatology 101 (20)

Diagnosis & Management of Chronic Liver Disease.ppt
Diagnosis & Management of Chronic Liver Disease.pptDiagnosis & Management of Chronic Liver Disease.ppt
Diagnosis & Management of Chronic Liver Disease.ppt
 
Liver absite
Liver absiteLiver absite
Liver absite
 
Ascites
AscitesAscites
Ascites
 
Gallbladder disease galster
Gallbladder disease   galsterGallbladder disease   galster
Gallbladder disease galster
 
Complications of Liver Disease (Academic Day Seminar)
Complications of Liver Disease (Academic Day Seminar)Complications of Liver Disease (Academic Day Seminar)
Complications of Liver Disease (Academic Day Seminar)
 
Git Case Budd Chiari3.
Git Case Budd Chiari3.Git Case Budd Chiari3.
Git Case Budd Chiari3.
 
upper G I Bleed (non variceal)
upper G I Bleed (non variceal)upper G I Bleed (non variceal)
upper G I Bleed (non variceal)
 
Surgery cholangitis[1]
Surgery cholangitis[1]Surgery cholangitis[1]
Surgery cholangitis[1]
 
acutepancreatitis-190207120812 (1).pdf (1).pptx
acutepancreatitis-190207120812 (1).pdf (1).pptxacutepancreatitis-190207120812 (1).pdf (1).pptx
acutepancreatitis-190207120812 (1).pdf (1).pptx
 
Chronic liver disease in children22.pptx
Chronic liver disease in children22.pptxChronic liver disease in children22.pptx
Chronic liver disease in children22.pptx
 
Management of ascites~8 b958
Management of  ascites~8 b958Management of  ascites~8 b958
Management of ascites~8 b958
 
Hematemesis in children-Beyond Infancy
Hematemesis in children-Beyond InfancyHematemesis in children-Beyond Infancy
Hematemesis in children-Beyond Infancy
 
Obstructive jaundice
Obstructive  jaundiceObstructive  jaundice
Obstructive jaundice
 
Jaundice and LFT interpretation
Jaundice and LFT interpretationJaundice and LFT interpretation
Jaundice and LFT interpretation
 
Liver Disease
Liver DiseaseLiver Disease
Liver Disease
 
Acute GI bleed
Acute GI bleedAcute GI bleed
Acute GI bleed
 
3. ASCITES part 1.pdf
3. ASCITES part 1.pdf3. ASCITES part 1.pdf
3. ASCITES part 1.pdf
 
Biliary emergencies.pptx
Biliary emergencies.pptxBiliary emergencies.pptx
Biliary emergencies.pptx
 
seminar on Haematuria
seminar on Haematuriaseminar on Haematuria
seminar on Haematuria
 
Gastroenterology Tutorial
Gastroenterology TutorialGastroenterology Tutorial
Gastroenterology Tutorial
 

More from derosaMSKCC

Heme talk 10 29-15- dr james
Heme talk 10 29-15- dr  jamesHeme talk 10 29-15- dr  james
Heme talk 10 29-15- dr james
derosaMSKCC
 
Vte path and rx
Vte path and rx Vte path and rx
Vte path and rx
derosaMSKCC
 
Coag testing for hema fellows mskcc 10 15 2015 dr peerschke
Coag testing for hema fellows mskcc 10 15 2015   dr  peerschkeCoag testing for hema fellows mskcc 10 15 2015   dr  peerschke
Coag testing for hema fellows mskcc 10 15 2015 dr peerschke
derosaMSKCC
 
Hemophilia fellow talk2015 dr parameswaran
Hemophilia fellow talk2015    dr  parameswaranHemophilia fellow talk2015    dr  parameswaran
Hemophilia fellow talk2015 dr parameswaran
derosaMSKCC
 
Drug induced hemolytic anemia cc 10 8-15 - dr mehta-shah
Drug induced hemolytic anemia cc 10 8-15 - dr  mehta-shahDrug induced hemolytic anemia cc 10 8-15 - dr  mehta-shah
Drug induced hemolytic anemia cc 10 8-15 - dr mehta-shah
derosaMSKCC
 
Heme conf 10 08-2015 - dr cho
Heme conf 10 08-2015 - dr  choHeme conf 10 08-2015 - dr  cho
Heme conf 10 08-2015 - dr choderosaMSKCC
 
Immunotherapy 101
Immunotherapy 101Immunotherapy 101
Immunotherapy 101derosaMSKCC
 
heme_case_092415
heme_case_092415heme_case_092415
heme_case_092415
derosaMSKCC
 
update on blood product alternatives
update on blood product alternativesupdate on blood product alternatives
update on blood product alternatives
derosaMSKCC
 
Vwd
Vwd Vwd
Chest pain
Chest painChest pain
Chest pain
derosaMSKCC
 
Surgery residents guide to stop sepsis
Surgery residents guide to stop sepsisSurgery residents guide to stop sepsis
Surgery residents guide to stop sepsis
derosaMSKCC
 
Coag cascade for fellows
Coag cascade for fellowsCoag cascade for fellows
Coag cascade for fellows
derosaMSKCC
 
August orientation 2015 molly
August orientation 2015 mollyAugust orientation 2015 molly
August orientation 2015 molly
derosaMSKCC
 
Orientation 2015
Orientation 2015Orientation 2015
Orientation 2015derosaMSKCC
 
Orientation 2014 viola
Orientation 2014 violaOrientation 2014 viola
Orientation 2014 violaderosaMSKCC
 
Rotator chief orientation 2015 2016
Rotator chief orientation 2015 2016Rotator chief orientation 2015 2016
Rotator chief orientation 2015 2016derosaMSKCC
 
Anticoagulant Reversal
Anticoagulant ReversalAnticoagulant Reversal
Anticoagulant ReversalderosaMSKCC
 
Platelet apocalypse 2015
Platelet apocalypse 2015Platelet apocalypse 2015
Platelet apocalypse 2015derosaMSKCC
 
Thalassemia syndromes mskcc 4 9-15
Thalassemia syndromes mskcc 4 9-15Thalassemia syndromes mskcc 4 9-15
Thalassemia syndromes mskcc 4 9-15derosaMSKCC
 

More from derosaMSKCC (20)

Heme talk 10 29-15- dr james
Heme talk 10 29-15- dr  jamesHeme talk 10 29-15- dr  james
Heme talk 10 29-15- dr james
 
Vte path and rx
Vte path and rx Vte path and rx
Vte path and rx
 
Coag testing for hema fellows mskcc 10 15 2015 dr peerschke
Coag testing for hema fellows mskcc 10 15 2015   dr  peerschkeCoag testing for hema fellows mskcc 10 15 2015   dr  peerschke
Coag testing for hema fellows mskcc 10 15 2015 dr peerschke
 
Hemophilia fellow talk2015 dr parameswaran
Hemophilia fellow talk2015    dr  parameswaranHemophilia fellow talk2015    dr  parameswaran
Hemophilia fellow talk2015 dr parameswaran
 
Drug induced hemolytic anemia cc 10 8-15 - dr mehta-shah
Drug induced hemolytic anemia cc 10 8-15 - dr  mehta-shahDrug induced hemolytic anemia cc 10 8-15 - dr  mehta-shah
Drug induced hemolytic anemia cc 10 8-15 - dr mehta-shah
 
Heme conf 10 08-2015 - dr cho
Heme conf 10 08-2015 - dr  choHeme conf 10 08-2015 - dr  cho
Heme conf 10 08-2015 - dr cho
 
Immunotherapy 101
Immunotherapy 101Immunotherapy 101
Immunotherapy 101
 
heme_case_092415
heme_case_092415heme_case_092415
heme_case_092415
 
update on blood product alternatives
update on blood product alternativesupdate on blood product alternatives
update on blood product alternatives
 
Vwd
Vwd Vwd
Vwd
 
Chest pain
Chest painChest pain
Chest pain
 
Surgery residents guide to stop sepsis
Surgery residents guide to stop sepsisSurgery residents guide to stop sepsis
Surgery residents guide to stop sepsis
 
Coag cascade for fellows
Coag cascade for fellowsCoag cascade for fellows
Coag cascade for fellows
 
August orientation 2015 molly
August orientation 2015 mollyAugust orientation 2015 molly
August orientation 2015 molly
 
Orientation 2015
Orientation 2015Orientation 2015
Orientation 2015
 
Orientation 2014 viola
Orientation 2014 violaOrientation 2014 viola
Orientation 2014 viola
 
Rotator chief orientation 2015 2016
Rotator chief orientation 2015 2016Rotator chief orientation 2015 2016
Rotator chief orientation 2015 2016
 
Anticoagulant Reversal
Anticoagulant ReversalAnticoagulant Reversal
Anticoagulant Reversal
 
Platelet apocalypse 2015
Platelet apocalypse 2015Platelet apocalypse 2015
Platelet apocalypse 2015
 
Thalassemia syndromes mskcc 4 9-15
Thalassemia syndromes mskcc 4 9-15Thalassemia syndromes mskcc 4 9-15
Thalassemia syndromes mskcc 4 9-15
 

Recently uploaded

BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
DR SETH JOTHAM
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
MedicoseAcademics
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
Levi Shapiro
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
Surgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptxSurgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptx
jval Landero
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
kevinkariuki227
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Anujkumaranit
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
Shweta
 
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyayaCharaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Dr KHALID B.M
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
LanceCatedral
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
Catherine Liao
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
VarunMahajani
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
Sujoy Dasgupta
 
THOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation ActTHOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation Act
DrSathishMS1
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 

Recently uploaded (20)

BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
Surgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptxSurgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptx
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyayaCharaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
 
THOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation ActTHOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation Act
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 

Hepatology 101

  • 1. Hepatology 101 August 20, 2015 Douglas Koo, MD, MPH, FACP Department of Medicine, Hospital Medicine Service
  • 4. Case HPI: duration of exposure and LFT abnormalities PMH: DM, high BMI, autoimmune disease, transfusion or transplant before 1972 (HBV) or 1992 (HCV) Meds: new meds, vitamins, herbals, OTCs, acetaminophen FH: liver disease, autoimmune disease SH: alcohol consumption, occupational exposure, travel, from viral hepatitis endemic areas, IVDU, tattoos ROS: jaundice, rash, arthralgia, myalgia, anorexia, weight loss, abdominal pain, fever, chills, pruritus PE: Encephalopathy (inverted sleep-wake, irritability, tremor, confusion), asterixis, jaundice, temporal wasting, scleral or sublingual icterus, fetor hepaticus, JVD, spider angiomata, gynecomastia, hepatomegaly, splenomegaly, caput medusae, ascites, testicular atrophy, thenar atrophy, palmar erythema, Dupuytren’s contractures, LE edema
  • 5. LFTs • Total Protein 8.2 • Albumin 4.6 • TBili 18.9 • AST 1460 • ALT 2645 • Alk Phos 120 • PT 16.4 • INR 1.39 • PTT 35.8
  • 6. LFTs: the players LFT Abnormality measured Notes Albumin Synthetic function Heavy alcohol use, chronic inflammation, malnutrition PT/INR Synthetic function Low vitamin K, warfarin AST Hepatocellular damage High concentrations in cardiac tissue, skeletal muscle, blood ALT Hepatocellular damage Low concentrations in non- hepatic tissue; more specific Bilirubin Cholestasis, impaired conjugation, biliary obstruction Hemolysis Alkaline phosphatase Cholestasis, infiltrative disease, biliary obstruction Bone disease, leukemia, lymphoma, CKD, CHF, sarcoidosis, hyperthyroidism, hyperparathyroidism, pregnancy, post-prandial
  • 7. LFT pattern is important for DDx HEPATOCELLULAR ALT, AST > Alk Phos CHOLESTATIC Alk Phos > ALT, AST *Bilirubin can be elevated in both and do not help to distinguish
  • 8. Hepatocellular pattern: AST, ALT in disease Quinn PG, Johnston DE. Gastroenterologist 1997.
  • 9. Hepatocellular pattern Mild (<5x nl) Severe(>15x nl) Steatosis/steatohepatitis Chronic hepatitis B, C Alcohol hepatitis (2:1 AST/ALT ratio) Cirrhosis Acute viral hepatitis (A-E, EBV, CMV) Medications/toxins Autoimmune hepatitis Wilson’s disease Hemochromatosis Alpha1 antitrypsin deficiency Celiac disease Nonhepatic: Hemolysis Myopathy (3:1 ratio) Thyroid disease Strenuous exercise Acute viral hepatitis (A-E, EBV, CMV) Medications/toxins Autoimmune hepatitis Wilson’s disease Ischemic hepatitis Acute Budd-Chiari syndrome Acute bile duct obstruction
  • 10. Back to the case Acute viral hepatitis (A-E, EBV, CMV) Medications/toxins Autoimmune hepatitis Wilson’s disease Ischemic hepatitis Acute Budd-Chiari syndrome Acute bile duct obstruction • Total Protein 8.2 • Albumin 4.6 • TBili 18.9 • AST 1460 • ALT 2645 • Alk Phos 120 Hep A total Ab positive Hep A IgMAb negative Hep B surface Ab positive Hep B surface Ag negative Hep B core Ab negative Hep B PCR <5 IU/mL Hep C antibody negative Hep C PCR <10 IU/mL
  • 12. Cholestatic pattern Confirm hepatobiliary source (check GGT) RUQ sono Dilated bile ducts Non-dilated bile ducts Extrahepatic cholestasis Intrahepatic cholestasis ERCP, MRCP, or CT Check AMA PBC ERCP, MRCP or biopsy Malignant - Hepatobiliary tumor - Porta hepatis node Benign - Choledocholithiasis - Chronic pancreatitis - HIV cholangiopathy - Parasitic infections PBC PSC TPN Sepsis Pregnancy Hepatic congestion/CHF Drugs (steroids, Bactrim) Infiltrative diseases (sarcoid, amyloid, lymphoma,TB, fungal, HCC, mets)
  • 13. Isolated hyperbilirubinemia Unconjugated/Indirect Conjugated/Direct Increased production - Hemolysis - Dyserythropoiesis -Transfusion - Large hematoma resorption Impaired uptake - CHF - Portosystemic shunt - Meds Impaired conjugation - Gilbert’s syndrome - Crigler-Najjar syndrome - Hyperthyroidism - hepatitis, cirrhosis,Wilson’s *see pathway for Cholestatic pattern
  • 16. Case • 52F metastatic colon adenocarcinoma – diagnosed 2y ago, mets to lung, liver, bone, peritoneum – p/w fever 101 at home, chills, rigors, mild abdominal pain • PMH/PSH: biliary stent placed 3wks prior, PE, hypothyroidism, depression, GERD, colectomy, HAIP, cholecystectomy, liver resection, RFA lung mets • MEDS: enoxaparin, synthroid, escitalopram, pantoprazole, celecoxib, fentanyl patch, hydromorphone, laxatives • SH: current 15pk-yr smoker, social EtOH, married • ROS: +epigastric abd pain, +nausea, +vomiting, +rhinorrhea, +nasal congestion, -dyspnea, -chest pain, -cough, -hematuria, -dysuria, +dark urine, - jaundice
  • 17. Workup • PE: 37.6 80/54 112 18 95% RA, mild confusion, mild epigastric tenderness • Labs • Lactic acid 3.1 • UA +urobilinogen • Blood cultures pending • CXR negative 5 0.4 15 10 32 262 146 3.3 118 24 7 159 5.4 85 307 11.7 33.5 1.1 0.6 3 121
  • 18. Diagnosis • Cholangitis; Biliary sepsis – Ascending bacterial infection from duodenum – Charcot’s triad (fever, RUQ pain, jaundice) 50-75% – Reynold’s pentad (above + confusion and hypotension) – Up to 40% mortality rate from multiorgan failure (liver, kidney) – Significant endotoxemia – Risk factors: biliary obstruction and stasis (stone, stricture), stent – Imaging: US, CT, MRCP, ERCP, HIDA
  • 19. Management of cholangitis • Volume resuscitation/restore perfusion, antibiotics for polymicrobial infection (check out our ID website); 80% will respond • DRAINAGE! • Electrolyte management, correct coagulopathy • Consults: ICU, GI, IR (when percutaneous approach needed) • Urgent! Persistent pain, fever, hypotension, confusion
  • 22. Chole… • Cholangitis • Cholecystitis – 90% gallstones – 10% acalculous (critically ill, elderly, post-op) – ERCP vs cholecystectomy vs cholecystostomy • Chole(docho)lithiasis – Saturation of bile with cholesterol or bilirubin + stasis – Biliary “colic”: episodic RUQ or epigastric abdominal pain with quick onset and slow resolution min to hours, nausea, fatty foods • Imaging sensitivity: – Cholelithiasis: U/S>CT – Cholecystitis HIDA>CT=U/S
  • 23.
  • 25.
  • 26.
  • 27.
  • 28.
  • 29. Paracentesis Indications • To evaluate new onset ascites of unclear etiology • To evaluate for SBP (spontaneous bacterial peritonitis) in pt with known ascites • To perform large volume paracentesis and provide comfort or relieve respiratory compromise Contraindications • Coagulopathy? • Thrombocytopenia? • DIC • Abdominal wall collateral veins • Abdominal wall cellulitis • Surgical scars • Caution in: – Renal failure, organomegaly, bowel obstruction, intrabdominal adhesions, distended bladder
  • 30.
  • 31. Sites 2 cm below umbilicus in midline - linea alba lacks blood vessels RLQ or LLQ 2 to 4 cm medial and cephalad to ASIS - lateral to rectus sheath to avoid puncture of inferior epigastric artery An ultrasound study demonstrated that a LLQ tap site is superior to a midline site; the abdominal wall is relatively thinner in the left lower quadrant while the depth of fluid is greater Sakai H et al. Choosing the location for non-image guided abdominal paracentesis. Liver Int. 2005.
  • 32. Advancing catheter through skin Angular insertion Z-tract or
  • 33. Albumin after LVP in portal HTN & cirrhosis • “interesting” “unresolved” “controversial” • No study has shown a survival advantage • Reasonable to forego albumin if <5L LVP • I was taught give 50cc of 25% albumin (12.5g) per 2L removed • NEJM article and video: recommend use of albumin if >5 L of ascites removed (6 to 8 g per liter of fluid removed)
  • 34. Appearance of ascites • Clear/translucent yellow: uncomplicated in the setting of cirrhosis • Cloudy: infection • Milky: “chylous ascites”, high triglyceride concentration, cirrhosis or malignancy • Pink/bloody: traumatic tap, leakage from punctured collateral from previous tap, malignancy • Brown/molasses: if bilirubin is greater than serum, concern for ruptured gallbladder or perforated duodenal ulcer Diagnosis and evaluation of patients with ascites. UpToDate.
  • 35. 2 questions: Infection? Portal HTN? • Cell count: PMN > 250 cells/mm3 • If bloody or >50K RBCs, subtract 1 PMN for every 250 red cells • Culture used to confirm diagnosis of SBP – Volume affects culture sensitivity; goal 10cc per bottle – Fill culture bottles at bedside • SAAG = Ascites albumin value – Serum albumin value
  • 37.
  • 38. Malignant ascites • Median survival 1-4 months • Symptomatic relief – Diuretics – Tenckhoff catheter